DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
49 hedge funds and large institutions have $4.73M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $9.77M → $4.73M (-$5.04M)
Holders
49
Holding in Top 10
1
Calls
$267K
Puts
–
Top Buyers
| 1 | +$280K | |
| 2 | +$87K | |
| 3 | +$42K | |
| 4 |
SBLIC
Security Benefit Life Insurance Company
Topeka,
Kansas
|
+$34K |
| 5 |
SC
Shay Capital
New York
|
+$29K |
Top Sellers
| 1 | -$833K | |
| 2 | -$738K | |
| 3 | -$215K | |
| 4 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$172K |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$150K |